Latest filing published 10 Nov 2021 for MEDNAX, INC., €123k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
John C. Pepia: trading record in brief
John C. Pepia, listed as chief executive, appears in our data through filings on Pediatrix Medical Group, Inc. shares, published by SEC (Form 4). The record holds 31 filings, for trades running from 16 February 2017 to 10 November 2021.
Sales make up the whole of the open-market record (14 sales, €1.8M). Other entries cover 11 share grants and 6 option exercises. Since January 2021: no purchases and 3 sales on the market.
On 10 November 2021 came the latest disclosure, an open-market sale for €123k in Pediatrix Medical Group, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John C. Pepia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$28.4515.2% of flowCommon StockSEC:0001209191-21-063832:0
- 9,238 shares@ US$26.8726.3% of flowCommon StockSEC:0001209191-21-062083:0
- 10,000 shares@ US$31.8333.1% of flowCommon StockSEC:0001209191-21-054746:0
- 7,858 shares@ US$31.9825.4% of flowCommon StockSEC:0001209191-21-037166:0
4 of 4 declarations
